InvestorsObserver
×
News Home

Is Mereo BioPharma Group plc - ADR (MREO) Stock a Good Value?

Wednesday, May 11, 2022 09:54 AM | InvestorsObserver Analysts

Mentioned in this article

Is Mereo BioPharma Group plc - ADR (MREO) Stock a Good Value?

Mereo BioPharma Group plc - ADR (MREO) stock is lower by -88.69% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MREO stock a score of 21 out of a possible 100.

That rank is chiefly influenced by a long-term technical score of 1. MREO's rank also includes a short-term technical score of 2. The fundamental score for MREO is 61. In addition to the average rating from Wall Street analysts, MREO stock has a mean target price of $8.00. This means analysts expect the stock to climb 2062.16% over the next 12 months.
Overall Score - 21
MREO has an Overall Score of 21. Find out what this means to you and get the rest of the rankings on MREO!

What's Happening with MREO Stock Today

Mereo BioPharma Group plc - ADR (MREO) stock is down -14.9% while the S&P 500 has risen 0.38% as of 9:49 AM on Wednesday, May 11. MREO is lower by -$0.06 from the previous closing price of $0.43 on volume of 345,964 shares. Over the past year the S&P 500 has fallen -3.27% while MREO is lower by -88.69%. MREO lost -$0.02 per share in the over the last 12 months. Click Here to get the full Stock Report for Mereo BioPharma Group plc - ADR stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App